Robert J. Temple

Internal Medicine

3325 Rowland Pl NW
Washington, DC 20008

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Closing the gap: A United States perspective on enhancing drug evaluation in older adults.

Closing the gap: A United States perspective on enhancing drug evaluation in older adults.

Journal: Journal of the American Geriatrics Society

Published: February 29, 2024

Use of US Food and Drug Administration Expedited Drug Development and Review Programs by Orphan and Nonorphan Novel Drugs Approved From 2008 to 2021.

Use of US Food and Drug Administration Expedited Drug Development and Review Programs by Orphan and Nonorphan Novel Drugs Approved From 2008 to 2021.

Journal: JAMA network open

Published: November 01, 2022

Participation of Older Adults in Clinical Trials for New Drug Applications and Biologics License Applications From 2010 Through 2019.

Participation of Older Adults in Clinical Trials for New Drug Applications and Biologics License Applications From 2010 Through 2019.

Journal: JAMA network open

Published: October 14, 2022

Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial.

Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial.

Journal: JAMA network open

Published: May 31, 2022

U.S. racial and ethnic participation in global clinical trials by therapeutic areas.

U.S. racial and ethnic participation in global clinical trials by therapeutic areas.

Journal: Journal of clinical pharmacy and therapeutics

Published: August 10, 2021

An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease.

An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease.

Journal: The New England journal of medicine

Published: July 28, 2021

Roadmap to 2030 for Drug Evaluation in Older Adults.

Roadmap to 2030 for Drug Evaluation in Older Adults.

Journal: Clinical pharmacology and therapeutics

Published: March 23, 2021

Contents of US Food and Drug Administration Refuse-to-File Letters for New Drug Applications and Efficacy Supplements and Their Public Disclosure by Applicants.

Contents of US Food and Drug Administration Refuse-to-File Letters for New Drug Applications and Efficacy Supplements and Their Public Disclosure by Applicants.

Journal: JAMA internal medicine

Published: February 15, 2021

Farewell to our Wonderful Friend and Colleague, J. Richard (Dick) Crout (1929-2020).

Farewell to our Wonderful Friend and Colleague, J. Richard (Dick) Crout (1929-2020).

Journal: Clinical pharmacology and therapeutics

Published: September 23, 2020

Encouragement of subgroup assessment by the FDA.

Encouragement of subgroup assessment by the FDA.

Journal: Pharmaceutical statistics

Published: July 27, 2020

Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.

Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.

Journal: Circulation

Published: January 30, 2020

Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective.

Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective.

Journal: Journal of natural products

Published: January 25, 2020

Showing 1-12 of 54

Last Updated: 09/26/2026